RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000131.xml
Synfacts 2006(2): 0095-0095
DOI: 10.1055/s-2005-923599
DOI: 10.1055/s-2005-923599
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York
Synthesis of (±)-Renieramycin G
P. Magnus*, K. S. Matthews
University of Texas at Austin, USA
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
23. Januar 2006 (online)
![](https://www.thieme-connect.de/media/synfacts/200602/lookinside/thumbnails/10.1055-s-2005-923599-1.jpg)
Significance
(-)-Renieramycin is a metabolite from Xestospongia caycedoi with cytotoxicity of 0.5 and 1.0 µg/mL against KB and LoVo human cancer cell lines, respectively. The synthesis by Magnus and co-workers features a five-step sequence for the conversion of the electron-rich isoquinoline A into the 1,3-disubstituted tetrahydroisoquinoline C initiated by addition of benzyloxymethyllithium to the isoquinoline A. The strategy was also applied to a synthesis of (±)-Lemonomycinone.